Kodiak Sciences Inc. (KOD) income statement
NASDAQ · Healthcare · Biotechnology · 141 employees · CEO Victor Perlroth
- Price
- $99.18 -1.22%
- Market cap
- $6.23B
- Enterprise value
- $6.2B
- Last report
- Q2 '26 filed 2026-08-13
- Next report
- 2026-11-12 EPS est. -$1.06
Income statement
| Income statement | Trend | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of revenue | $6.97M | $6.66M | $6.65M | $6.68M | $6.7M | $6.68M | $0 | $0 | $0 | $0 | $0 | $0 | |
| Gross profit | -$6.97M | -$6.66M | -$6.65M | -$6.68M | -$6.7M | -$6.68M | $0 | $0 | $0 | $0 | $0 | $0 | |
| Research & development | $36.2M | $46.6M | $29.9M | $32.5M | $31.9M | $31.8M | $43.6M | $42.8M | $50.5M | $45.5M | $48.5M | $56.1M | |
| Sales & marketing | $0 | -$6.66M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| General & administrative | $0 | $16.7M | $0 | $0 | $0 | $0 | $13.5M | $12.8M | $11.9M | $12M | $11.2M | $10.8M | |
| Other operating expenses | $0 | $0 | $0 | $0 | $0 | $0 | $1.91M | $0 | $0 | $0 | $0 | $0 | |
| Operating expenses | $47.5M | $56.7M | $39.4M | $41.3M | $39.9M | $39.5M | $59.1M | $55.5M | $62.4M | $57.5M | $59.8M | $66.8M | |
| Operating income | -$54.5M | -$63.4M | -$46.1M | -$48M | -$46.6M | -$46.2M | -$59.1M | -$55.5M | -$62.4M | -$57.5M | -$59.8M | -$66.8M | |
| Interest income | $4.54M | $3.9M | $3.35M | $2.95M | $2.71M | $2.13M | $1.6M | $1.24M | $917K | $757K | $1.64M | $1.26M | |
| Interest expense | $5K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Other non-operating income (gains on investments, FX ...) | -$4.5M | -$3.86M | -$3.02M | -$2.87M | -$2.69M | -$2.07M | -$1.61M | -$1.2M | -$895K | -$4.42M | -$1.62M | -$60K | |
| Total non-operating income | $4.49M | $3.86M | $3.02M | $2.87M | $2.69M | $2.07M | $1.61M | $1.2M | $895K | $717K | $1.62M | $1.2M | |
| Income before tax | -$50M | -$59.5M | -$43M | -$45.1M | -$43.9M | -$44.1M | -$57.5M | -$54.3M | -$61.5M | -$56.7M | -$58.2M | -$65.6M | |
| Net income | -$50M | -$59.5M | -$43M | -$45.1M | -$43.9M | -$44.1M | -$57.5M | -$54.3M | -$61.5M | -$56.7M | -$58.2M | -$65.6M | |
| EPS (basic) | -$0.95 | -$1.13 | -$0.82 | -$0.86 | -$0.84 | -$0.84 | -$1.09 | -$1.03 | -$1.16 | -$1.04 | -$0.94 | -$1.05 | |
| EPS (diluted) | -$0.95 | -$1.13 | -$0.82 | -$0.86 | -$0.84 | -$0.84 | -$1.09 | -$1.03 | -$1.16 | -$1.04 | -$0.94 | -$1.05 | |
| Shares (basic, weighted) | 52.5M | 52.5M | 52.5M | 52.6M | 52.6M | 52.7M | 52.7M | 52.8M | 52.9M | 53.2M | 61.9M | 62.6M | |
| Shares (diluted, weighted) | 52.5M | 52.5M | 52.5M | 52.6M | 52.6M | 52.7M | 52.7M | 52.8M | 52.9M | 53.2M | 61.9M | 62.6M | |
| Depreciation & amortization | $6.97M | $6.66M | $6.65M | $6.68M | $6.7M | $6.68M | $6.73M | $6.54M | $6.54M | $6.52M | $6.34M | $6.19M | |
| EBITDA | -$43M | -$52.9M | -$36.4M | -$38.4M | -$37.2M | -$37.4M | -$50.7M | -$47.8M | -$54.9M | -$46.5M | -$51.8M | -$60.6M |
| Income statement | Trend | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of revenue | $257K | $549K | $490K | $911K | $4.21M | $8.71M | $11M | $25.9M | $26.7M | $0 | |
| Gross profit | -$257K | -$549K | -$490K | -$911K | -$4.21M | -$8.71M | -$11M | -$25.9M | -$26.7M | $0 | |
| Research & development | $14.1M | $22M | $18.8M | $37.5M | $107M | $217M | $268M | $206M | $126M | $182M | |
| General & administrative | $3.1M | $3.5M | $7.58M | $0 | $0 | $0 | $0 | $71M | $0 | $52M | |
| Other operating expenses | $25K | -$1.23M | -$4.07M | $0 | $0 | $0 | $0 | -$25.9M | $0 | $0 | |
| Operating expenses | $17.2M | $25.5M | $26.4M | $48.3M | $132M | $258M | $330M | $251M | $160M | $234M | |
| Operating income | -$17.2M | -$25.5M | -$26.4M | -$49.2M | -$136M | -$267M | -$341M | -$277M | -$187M | -$234M | |
| Interest income | $0 | $0 | $0 | $1.57M | $2.9M | $298K | $7.07M | $16.7M | $11.1M | $4.52M | |
| Interest expense | $6K | $1.19M | $5.52M | $8K | $25K | $22K | $18K | $13K | $0 | $0 | |
| Other non-operating income (gains on investments, FX ...) | -$25K | $1.23M | $9.55M | -$1.83M | -$2.94M | -$83K | -$7.57M | -$16.8M | -$10.6M | -$4.42M | |
| Total non-operating income | $19K | -$2.42M | -$15.1M | $1.83M | $2.91M | $61K | $7.56M | $16.8M | $10.6M | $4.42M | |
| Income before tax | -$17.1M | -$27.9M | -$41.4M | -$47.4M | -$133M | -$267M | -$334M | -$260M | -$176M | -$230M | |
| Income tax | $31K | -$45K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net income | -$17.1M | -$27.9M | -$41.4M | -$47.4M | -$133M | -$267M | -$334M | -$260M | -$176M | -$230M | |
| EPS (basic) | -$2.30 | -$1.05 | -$1.16 | -$1.23 | -$2.91 | -$5.16 | -$6.39 | -$4.97 | -$3.35 | -$4.32 | |
| EPS (diluted) | -$2.30 | -$1.05 | -$1.16 | -$1.23 | -$2.91 | -$5.16 | -$6.39 | -$4.97 | -$3.35 | -$4.32 | |
| Shares (basic, weighted) | 7.44M | 26.6M | 35.9M | 37.9M | 45.7M | 51.8M | 52.2M | 52.4M | 52.6M | 53.2M | |
| Shares (diluted, weighted) | 7.44M | 26.6M | 35.9M | 37.9M | 45.7M | 51.8M | 52.2M | 52.4M | 52.6M | 53.2M | |
| Depreciation & amortization | $257K | $549K | $490K | $911K | $4.21M | $8.71M | $11M | $25.9M | $26.7M | $26.3M | |
| EBITDA | -$16.9M | -$26.2M | -$35.4M | -$46.4M | -$129M | -$258M | -$323M | -$235M | -$150M | -$204M |
Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.
Revenue, operating income and growth
quarterlyMargins
quarterlyCosts as % of revenue
quarterlyThe other statements
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30
Data as of 2026-11-02